Over the same period, shares of Incyte Corp. have risen a healthy 49.6% on the back of several intriguing developments. Both companies have catalysts to look forward to.
Category: Incyte
Biotech Stocks: What to Watch in 2017
You probably didn’t like 2016 very much if you owned biotech stocks. Many biotech stocks, including some solid ones, performed dismally.